ADVERTISEMENT

Rutgers Alums have a COVID-19 Preventative Nasal Spray ready that could help bring Fall Football

RCBeta79

Junior
Jun 7, 2013
999
973
93
  1. EmphyCorp N115 News: Reducing the Rate and Spread of COVID-19 with Nasal Nitric Oxide (not Nitric Oxide Gas)...PR Newswire - April 7, 2020
http://www.prnewswire.com/news-rele...-nitric-oxide-301036890.html?tc=eml_cleartime

As cited in hundreds of peer reviewed publications, naturally occurring nitric oxide in the nasal cavities is a primary defense in humans that is needed to kill invading bacteria, fungi and viruses.

Nasal Nitric Oxide also prevents and reduces the rate and severity of viral infections, and viral replication from the Common Cold, Rhinoviruses, the Flu, and Coronavirus.

EmphyCorp Rx N115 Nasal Spray increases Nasal Nitric Oxide that kills invading bacteria and viruses, which is needed to reduce the rate, severity and spread of infections.

Note: Rx and OTC Nasal Sprays with Steroids, as well as other Steroid Treatments, shut down the synthesis of nasal nitric oxide which increases the rate of infections.

Note: Nasal steroids and other OTC nasal treatments shut down the synthesis of nasal nitric oxide, which then leads to decreased lung functions and a 34% increase in infections.

2. EmphyCorp News: As Reported in The Lancet – Clinical Features of Patients Infected with the 2019 novel Coronavirus in Wuhan, China....PR Newswire - March 24, 2020
EmphyCorp Rx N115 Non-Steroidal Nasal Spray could be used as a potential treatment to help alleviate the symptoms associated with the Coronavirus infections: hypoxemia, lung inflammation, inflammatory cytokines, coughing, and to reduce the rate and spread of infection in healthy individuals with no underlying health conditions and no COVID-19 infection.
http://www.prnewswire.com/news-releases/emphycorp-news-as-reported-in-the-lancet--clinical-features-of-patients-infected-with-the-2019-novel-coronavirus-in-wuhan-china-301029045.html?tc=eml_cleartime

3. EmphyCorp News: Nitric Oxide is currently being tested in Clinical Trials as a Potential Treatment for Patients infected with the Coronavirus...PR Newswire - March 17, 2020
http://www.prnewswire.com/news-rele...e-coronavirus-301025740.html?tc=eml_cleartime

We are ready to go....seeking a Pharmaceutical Company Partner to get our Drugs to Patients and to protect everyone else to the best of our ability.

Go Rutgers!








 
What's new about this compared to nose breathing during flu season? The talk of Nasal Nitric Oxcide has been around for years. And who or whom are the RU Alums working on this?
 
What's new about this compared to nose breathing during flu season? The talk of Nasal Nitric Oxcide has been around for years. And who or whom are the RU Alums working on this?

N115 is a Non-Steroidal Nasal Spray with no known side effects that increases your natural Nasal Nitric Oxide (not Nitric Oxide gas from a tank) that kills viruses, bacteria, and fungi.

N115 Non-Steroidal Nasal Spray completed Phase III Clinical Trials for Pulmonary Fibrosis with no known side effects and demonstrated significant improvement with congestion, lung inflammation, coughing, low oxygen, and lung infections.

If you read the Press Release, the two names mentioned are both Rutgers Alums. You will find (4) Alumni on the company website listed.
 
Last edited:
  • Like
Reactions: Yeah Baby and RC71
Well that explains it :Unhappy:

Rutgers Alumni: Alain Martin, Ph.d (Joint Rutgers and Yale) is the inventor (70+ Drug Patents), Stanley E Katz (Retired Medical Professor), Ron Amen (Global Regulatory Officer), Robert Millar (President).
 
Rutgers Alumni: Alain Martin, Ph.d (Joint Rutgers and Yale) is the inventor (70+ Drug Patents), Stanley E Katz (Retired Medical Professor), Ron Amen (Global Regulatory Officer), Robert Millar (President).
Thanks. Seriously. I have no time to research stuff now. Long days. Too tired today.
 
Full FDA approval? Looking for actual production without any formal government approval needed?
 
ADVERTISEMENT
ADVERTISEMENT